IL2RA and neoplasm: In addition to antibodies targeting CD25, Smyth and colleagues22 revealed that antibodies against other targets such as CTLA4, OX40 and GITR may facilitate the elimination of regulatory T cells in tumor microenvironment by effector functions of the antibody22–25.